Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Natural hydrolates may improve burn healing and fight antibiotic resistance.

New-onset fibromyalgia after COVID-19 is poorly understood, needing better definitions and studies.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Developing microRNA-based treatments is hard but has potential.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Most skin cysts were common types found in unusual body parts, and examining tissue samples is important for accurate diagnosis.

A fungal infection can look like a different scalp condition in teens, leading to wrong treatment until proper tests are done.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

Leflunomide is more likely to help treat alopecia areata than cause it.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

JAK inhibitors show promise for treating skin diseases effectively and safely.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

AgK114 protein helps in hamster skin injury recovery.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.